Article Versions Notes

Tabl AM, Ebeid ME, Ali YBM, Elawdan KA, Alalem M, Al-Eidan AA, Alalem N, Mansour AS, Awad AM, El-Madawy EA, et al. Nanomodified Nexavar Enhances Efficacy in Caco-2 Cells via Targeting Aspartate β-Hydroxylase-Driven Mitochondrial Cell Death. Immuno. 2026; 6(1):5. https://doi.org/10.3390/immuno6010005

Tabl, Ahmed M., Mohamed E. Ebeid, Yasser B. M. Ali, Khaled A. Elawdan, Mai Alalem, Ahood A. Al-Eidan, Nedaa Alalem, Ahmed S. Mansour, Ahamed M. Awad, Eman A. El-Madawy, and et al. 2026. "Nanomodified Nexavar Enhances Efficacy in Caco-2 Cells via Targeting Aspartate β-Hydroxylase-Driven Mitochondrial Cell Death" Immuno 6, no. 1: 5. https://doi.org/10.3390/immuno6010005

Tabl, A. M., Ebeid, M. E., Ali, Y. B. M., Elawdan, K. A., Alalem, M., Al-Eidan, A. A., Alalem, N., Mansour, A. S., Awad, A. M., El-Madawy, E. A., Elbuckley, S. A., Refaai, R., Elshamy, A. M., & Khalil, H. (2026). Nanomodified Nexavar Enhances Efficacy in Caco-2 Cells via Targeting Aspartate β-Hydroxylase-Driven Mitochondrial Cell Death. Immuno, 6(1), 5. https://doi.org/10.3390/immuno6010005